RGNTRegentis Biomaterials Ltd. Ordinary Shares

AMEX · US · Healthcare · Medical Instruments & Supplies · regentis.co.il

2.100USD-5.83%Mkt Cap: 14.75M $P/E: —3d ago

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacryla…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap14.75M $

Enterprise Value4.49M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-13.65M $

Revenue/Share—

Last Price2.100 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B2.29

EPS (TTM)-24.16

EPS (Forward)—

52W Range

1.2326% of range15.50

52W High15.50 USD

52W Low1.232 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-287.69%

ROA-179.15%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.38M $

CapEx (TTM)—

FCF Margin—

FCF Yield20.54%

Net Debt-6.18M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.25

Current Ratio2.65

Quick Ratio2.65

Book Value/Sh0.9160 USD

Cash/Share1.424 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)10.00 USD

Upside (mean)+376.2%

Target Range10.00 USD – 10.00 USD

# Analysts1

Ownership

Shares Out.7.02M

Float2.42M

Insiders14.04%

Institutions25.19%

Short Interest

Short Ratio0.2d

Short % Float0.73%

Short % Out.0.53%

Shares Short37.13K

Short (prev mo.)143.05K

Technical

SMA 502.893 (-27.4%)

SMA 2003.850 (-45.5%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)109.46K

Avg Vol (10d)58.03K

Technical Indicators

RSI (14)47.8

MACD-0.1363

MACD Signal-0.2123

MACD Hist.+0.0760

BB Upper2.209 USD

BB Middle1.948 USD

BB Lower1.688 USD

BB Width26.78%

ATR (14)0.2804 USD

Vol Ratio (20d)0.50x